Assignee
NEUMORA THERAPEUTICS INC
US·15 granted patents·17 pending applications·12 citations·filing 2018–2025
Top patents by PatentIndex Score
32 records- 0193US11742076B2Machine learning systems for generating multi-modal data archetypesNEUMORA THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·5 cites·20 claims
- 0293US11670417B2Machine learning systems for processing multi-modal patient dataNEUMORA THERAPEUTICS INC·Filed 2022·Granted Jun 6, 2023·5 cites·26 claims
- 0387US12087446B2Multimodal dynamic attention fusionNEUMORA THERAPEUTICS INC·Filed 2022·Granted Sep 10, 2024·2 cites·26 claims
- 0483US2024136058A1Machine learning systems for anchoring dimensions of latent spacesNEUMORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0582US12371414B2Methods of treating neurological disordersNEUMORA THERAPEUTICS INC·Filed 2024·Granted Jul 29, 2025·0 cites·6 claims
- 0682US11993580B1Methods of treating neurological disordersNEUMORA THERAPEUTICS INC·Filed 2023·Granted May 28, 2024·0 cites·6 claims
- 0782US2024062847A1Methods and systems for computer-generated predictive application of neuroimaging and gene expression mapping dataNEUMORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0882US2024021298A1Conditioning multi-modal patient dataNEUMORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0980US12002590B2Machine learning-based diagnostic classifierNEUMORA THERAPEUTICS INC·Filed 2023·Granted Jun 4, 2024·0 cites·20 claims
- 1080US2023343461A1Machine learning-based diagnostic classifierNEUMORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1179US2023343446A1Machine learning for predicting response scores for drugsNEUMORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1278US11798681B2Machine learning systems for training encoder and decoder neural networksNEUMORA THERAPEUTICS INC·Filed 2022·Granted Oct 24, 2023·0 cites·24 claims
- 1377US2024197220A1Systems and methods for screening, diagnosing, and stratifying patientsNEUMORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1476US2026062401A1Methods of treating neurological disordersNEUMORA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1576US2023260634A1Machine learning systems for processing multi-modal patient dataNEUMORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1675US11887724B2Estimating uncertainty in predictions generated by machine learning modelsNEUMORA THERAPEUTICS INC·Filed 2022·Granted Jan 30, 2024·0 cites·20 claims
- 1774US2024355480A1System and method for identifying transdiagnostic features shared across mental health disordersNEUMORA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1873US2023365534A1Modulators of nlrp3 inflammasome and related products and methodsNEUMORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1972US11842793B2Methods and tools for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subjectNEUMORA THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·19 claims
- 2071US2025304560A1Modulators of nlrp3 inflammasome and related products and methodsNEUMORA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2167US11858943B2Vasopressin receptor antagonists and products and methods related theretoNEUMORA THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·0 cites·16 claims
- 2266US12171758B1Crystalline salt forms of kappa opioid receptor antagonist and products and methods related theretoNEUMORA THERAPEUTICS INC·Filed 2024·Granted Dec 24, 2024·0 cites·30 claims
- 2365US11791016B2Methods and systems for computer-generated predictive application of neuroimaging and gene expression mapping dataNEUMORA THERAPEUTICS INC·Filed 2018·Granted Oct 17, 2023·0 cites·25 claims
- 2465US2026015357A1Modulators of nlrp3 inflammasome and related products and methodsNEUMORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2564US2026024669A1Identifying core patients in patient clusters using machine learningNEUMORA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2663US2026056993A1Generating and querying biological data graphs using machine learning modelsNEUMORA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2763US2025074888A1Pyridazine derivatives as modulators of nlrp3 inflammasome and related methodsNEUMORA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2859US12152038B2Vasopressin receptor antagonists and products and methods related theretoNEUMORA THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·0 cites·123 claims
- 2951US2024221950A1Multi-modal input processingNEUMORA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3050US2024415433A1Systems and methods for detecting anxiety using eegNEUMORA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3148US12232848B2System and method of facial analysisNEUMORA THERAPEUTICS INC·Filed 2020·Granted Feb 25, 2025·0 cites·31 claims
- 3245US12247037B21-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disordersNEUMORA THERAPEUTICS INC·Filed 2019·Granted Mar 11, 2025·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when NEUMORA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →